How to investigate Adherence to Antiretroviral Treatment ... - INRUD
How to investigate Adherence to Antiretroviral Treatment ... - INRUD
How to investigate Adherence to Antiretroviral Treatment ... - INRUD
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>How</strong> <strong>to</strong> Investigate <strong>Adherence</strong> <strong>to</strong> <strong>Antiretroviral</strong> <strong>Treatment</strong> in Health Facilities: <strong>Adherence</strong> Indica<strong>to</strong>rs<br />
12. Presence of labora<strong>to</strong>ry—Does the facility have access <strong>to</strong> a functioning labora<strong>to</strong>ry system<br />
for measuring CD4 counts or viral loads so that results can be ready for the patient's next<br />
routine visit?<br />
Rationale<br />
Source of data<br />
Data collection<br />
Computation<br />
Comments<br />
A functioning labora<strong>to</strong>ry that can measure CD4 counts or viral loads in or near the<br />
facility or within the programme makes it more likely that these clinical markers will<br />
be moni<strong>to</strong>red on a regular basis, which can promote discussion about adherence.<br />
Facility interview and observation<br />
At the time of data collection, ask whether the facility has a functioning labora<strong>to</strong>ry<br />
on-site, within the programme or within a five minutes’ walk that can produce CD4<br />
or viral load results in time for the patient's next routine visit and whether the test<br />
or transport would cost the patient anything.<br />
If the labora<strong>to</strong>ry is functioning and provide the test and transportation for free, then<br />
record Yes. Otherwise, record No.<br />
Labora<strong>to</strong>ry needs <strong>to</strong> be functioning on the day of data collection<br />
Some facilities have access <strong>to</strong> a labora<strong>to</strong>ry in a central facility within their programme and<br />
may either take blood <strong>to</strong> send <strong>to</strong> the facility or send the patient <strong>to</strong> the central facility for<br />
testing. From the patient’s point of view, the first option is much easier and less time<br />
consuming. If patients have <strong>to</strong> pay for their own transport, many may not be able <strong>to</strong> afford it.<br />
This then would not be defined as access.<br />
13. CD4 and viral load testing rate<br />
Rationale<br />
Source of data<br />
Data collection<br />
Computation<br />
Comments<br />
Increase in CD4 count over time is an indirect measure of success in controlling<br />
HIV; routine testing for CD4 can assist in adherence moni<strong>to</strong>ring<br />
Facility interview<br />
While doing the facility interview, ask about the intended frequency for CD4 and<br />
viral load tests and whether the intended frequency is met.<br />
CD4 testing rate—The stated number of months between routine CD4 tests for<br />
each patient<br />
Viral load testing rate—The stated number of months between routine viral load<br />
tests for each patient<br />
Not all facilities do routine CD4 counts or viral loads for all patients. Many facilities<br />
may claim <strong>to</strong> do them routinely but in fact do not. This method does not allow for<br />
checking this.<br />
18